Satio Successfully Completes Development and Testing of Novel At-Home, Remotely Controllable, Intradermal Drug Delivery System, Achieving the First Fully Executed ARPA-H Small Business Contract
BOSTON, April 7, 2025 /PRNewswire/ -- Satio, Inc. is pleased to announce the successful completion of a Small Business Innovation Research contract awarded by the Advanced Research Projects Agency for